Industry News
News From The Annals Of Internal Medicine: July 19, 2011
Jul 19, 2011
1. Testing for the Lynch Syndrome in All Colorectal Cancer Patients Cost-effective Relatives of Those Who Test Positive Are at Increased Risk and Should Also be Tested The Lynch syndrome is the most common genetic cause of colorectal cancer and is also associated with endometrial and other types of cancer... Read More
14 Leading Edge Studies Shared By John Theurer Cancer Center Researchers Shared At Recent ASCO Meeting
Jul 19, 2011
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center presented results from 14 cancer-related studies during the recently concluded American Society of Clinical Oncology (ASCO) Annual Meeting, which took place June 3 - 7, 2011 in Chicago. The studies examined new cancer treatments, ways to predict the best treatment outcomes, and patient quality of life issues... Read More
Publication Of New Meta-Analysis Examining Lack Of Efficacy Of Interleukin-2 As Monotherapy In AML Remission Maintenance
Jul 18, 2011
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) announced today the publication of a new meta-analysis which concluded that interleukin-2 (IL-2) monotherapy is not effective as a maintenance therapy for acute myeloid leukemia (AML) patients in first complete remission... Read More
Lymphoma Drug Shrinks Tumors In Dogs, Could Lead To Human Treatment
Jul 18, 2011
There are many kinds of cancers of the immune system, but one, Activated B-Cell Diffuse Large B-Cell Lymphoma, or ABC-DLBCL, is particularly common and pernicious... Read More
Research Reveals That Significantly More Genetic Mutations Lead To Colon Cancer
Jul 16, 2011
Researchers at UT Southwestern Medical Center say there are at least 70 genetic mutations involved in the formation of colon cancer, far more than scientists previously thought. Based on the study, published in the July 2011 Cancer Research (Priority Reports), researchers are suggesting a new approach to colon cancer treatments targeting multiple genes and pathways simultaneously... Read More
BioMarin Initiates Phase 1 Trial For BMN 673 In Patients With Advanced Hematological Malignancies
Jul 16, 2011
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced the initiation of a Phase 1 trial for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, for the treatment of patients with advanced hematological malignancies. A Phase 1/2 trial for BMN 673 for the treatment of patients with solid tumors was initiated in January 2011 and is ongoing... Read More
Genes: Ready, Go!
Jul 16, 2011
Just like orchestra musicians waiting for their cue, RNA polymerase II molecules are poised at the start site of many developmentally controlled genes, waiting for the "Go!"- signal to read their part of the genomic symphony... Read More
Camels At The Root Of Potential New Cancer Gene Therapy
Jul 15, 2011
Nanobodies produced by camels have unique properties, which can be used in future drug development. New research published in the Journal of Controlled Release confirms that nanobodies can help scientists in the fight against cancer. Members of the camelid family have particular heavy-chain antibodies in their blood known as nanobodies, that may serve as therapeutic proteins... Read More
More Frequent Cancer Screening Is Required To Update Patient's Family History Of Cancer Every 5-10 Years
Jul 15, 2011
The results of a study published in the July 13 issue of JAMA have revealed that throughout adulthood considerable changes occur in a patient's family history related to colorectal, breast, and prostate cancer between the ages of 30 and 50 years. This calls for more frequent cancer screening with the patient's family history of cancer being reviewed every 5 to 10 years... Read More
Early-Stage Melanoma Tumors Contain Clues To Metastatic Potential
Jul 15, 2011
Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal. Most deaths from cancer result from tumor cells that have strayed from their original location to insinuate their way into distant tissues... Read More
Previous Page Next Page